Reaction

Cardiac Ventricular Thrombosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,247 reports · 47 co-occurring drugs

As of the last recalculation, Cardiac Ventricular Thrombosis appears in 1,247 FAERS reports alongside 47 co-occurring drug terms. The strongest observed disproportionality signal is PEGASPARGASE (PRR 41.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Pegaspargase	30	41.9	42.0
Ticagrelor	53	28.9	29.0
Testosterone	37	27.2	27.2
Testosterone Cypionate	14	26.4	26.5
Heparin Sodium	21	25.9	25.9
Mercaptopurine	25	24.5	24.6
Eplerenone	18	23.8	23.8
Alteplase	20	22.6	22.6
Mesna Injection	11	22.4	22.4
Mesna	11	22.0	22.0
Nevirapine	11	20.5	20.5
Abacavir Sulfate	11	19.0	19.0
Chlorhexidine Gluconate	10	18.4	18.4
Tenofovir Disoproxil Fumarate Tablets	9	17.5	17.5
Methylprednisolone Acetate	8	16.8	16.8
Gentamicin	11	14.2	14.2
Zidovudine	11	13.8	13.9
Sirolimus	11	13.7	13.8
Apixaban	52	13.5	13.5
Blinatumomab	8	12.9	12.9
Clopidogrel Bisulfate	70	12.0	12.1
Gentamicin Sulfate	11	11.7	11.7
Ceftriaxone	21	10.8	10.9
Filgrastim	24	10.8	10.8
Erythropoietin	12	9.8	9.8
Vincristine Sulfate	17	9.8	9.8
Fluorouracil Cream, 0.5%	43	9.7	9.7
Dapagliflozin	18	9.7	9.7
Fluorouracil	43	9.6	9.6
Norepinephrine	6	9.4	9.4
Pertuzumab	15	9.3	9.3
Trastuzumab	37	9.2	9.2
Dabigatran Etexilate	37	8.2	8.2
Ado-Trastuzumab Emtansine	4	7.9	7.9
Rivaroxaban	91	7.8	7.8
Baricitinib	4	6.9	6.9
Tolvaptan	6	6.9	6.9
Prasugrel Hydrochloride	4	6.6	6.6
Inclisiran	3	6.3	6.3
Sacubitril And Valsartan	39	5.8	5.8
Tafamidis	4	5.7	5.7
Dabigatran Etexilate Mesylate	24	5.6	5.6
Lenvatinib	10	5.1	5.1
Cetuximab	9	4.8	4.8
Budesonide, Glycopyrrolate, And Formoterol Fumarate	3	4.8	4.8
Atezolizumab	10	4.3	4.3
Osimertinib	6	3.1	3.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.